SCHV vs VHT
Schwab US Large-Cap Value ETF vs Vanguard Health Care ETF
- • SCHV has the lower expense ratio at 0.04% vs 0.09% for VHT.
- • SCHV pays a higher dividend yield (1.85%).
Side-by-side metrics
| Metric | SCHV | VHT |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.04% | 0.09% |
Dividend yield Trailing 12-month yield. | 1.85% | 1.72% |
AUM Assets under management — bigger funds are typically more liquid. | $15.17B | $18.51B |
YTD return | 11.49% | -4.77% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.82 | 0.64 |
P/E ratio | 21.96 | 25.44 |
Last price | $32.47 | $271.09 |
Inception | — | — |
Issuer | Schwab | Vanguard |
SCHV top holdings
| BRK-B | Berkshire Hathaway Inc Class B | 2.97% |
| JPM | JPMorgan Chase & Co | 2.84% |
| XOM | Exxon Mobil Corp | 2.20% |
| MU | Micron Technology Inc | 1.99% |
| WMT | Walmart Inc | 1.91% |
| JNJ | Johnson & Johnson | 1.86% |
| INTC | Intel Corp | 1.51% |
| CAT | Caterpillar Inc | 1.28% |
| ABBV | AbbVie Inc | 1.23% |
| CVX | Chevron Corp | 1.23% |
VHT top holdings
| LLY | Eli Lilly and Co | 11.89% |
| JNJ | Johnson & Johnson | 9.34% |
| ABBV | AbbVie Inc | 6.18% |
| MRK | Merck & Co Inc | 4.80% |
| UNH | UnitedHealth Group Inc | 3.94% |
| AMGN | Amgen Inc | 3.05% |
| TMO | Thermo Fisher Scientific Inc | 2.97% |
| ABT | Abbott Laboratories | 2.87% |
| GILD | Gilead Sciences Inc | 2.78% |
| ISRG | Intuitive Surgical Inc | 2.63% |
About SCHV
SCHV (Schwab US Large-Cap Value ETF) is Large-cap US value at low cost. Managed by Schwab, the fund carries $15.2B in assets under management, an expense ratio of 0.04%, a dividend yield of 1.85%. Its largest holding is Berkshire Hathaway Inc Class B (BRK-B), which represents 3.0% of the portfolio. Real Estate is the fund's largest sector exposure at 4.1%.
About VHT
VHT (Vanguard Health Care ETF) is US health care sector stocks. Managed by Vanguard, the fund carries $18.5B in assets under management, an expense ratio of 0.09%, a dividend yield of 1.72%. Its largest holding is Eli Lilly and Co (LLY), which represents 11.9% of the portfolio. Technology is the fund's largest sector exposure at 0.0%.